BioCentury
ARTICLE | Finance

Hail the Local Hero

Euro and Canadian names get the most biopharma sellside analyst coverage

May 17, 2010 7:00 AM UTC

European and Canadian pharma and biotech companies have more analyst coverage than their American peers, because they get coverage by U.S. as well as local analysts, according to a review byBMO Capital Markets.

In fact, the top six companies in terms of sellside research coverage are all based in Europe: AstraZeneca plc (LSE:AZN; NYSE:AZN); GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); Novartis AG (NYSE:NVS; SIX:NOVN); sanofi-aventis Group (Euronext:SAN; NYSE:SNY); Novo Nordisk A/S (CSE:NVO; NYSE:NVO); and Roche (SIX:ROG; OTCQX:RHHBY)...